United Therapeutics Corporation UTHR
596.13 USD -2.59 -0.43%
At close · Nov 2
596.13 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
430.02 52-week range 609.99
- YTD
- +22.35%
- 1 year
- +33.83%
- Open
- 596.54
- Prev close
- 598.72
- Mkt cap
- 25.57B
- Vol
- 419.87K
- Avg vol
- 716.02K
- EPS
- 27.92
- P/E
- 21.35
- Div yield
- 0.00%
More statistics
- Low
- 592.47
- High
- 600.90
- Forward P/E
- 17.59
- Beta
- 0.48
- Short ratio
- 2.42
- Inst. own
- 100.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 527.10
- 200-d avg
- 531.54
- 1y target
- 670.93
MAX chart
Chart tools
Chart is warming up
The all-time price history for UTHR has not been loaded yet. Try again in a moment.
Altman Z-Score
22.13 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 3
- P/B 2
P/E 16.2×
P/S 6.8×
P/B 3.0×
P/FCF 20.7×
EV/EBITDA 11.0×
EV/Sales 6.3×
FCF Yield 4.8%
Gross Margin 87.9%
Operating Margin 47.7%
Net Margin 41.9%
ROE 18.8%
ROIC 16.1%
ROA 16.9%
Revenue 10.6%
Operating Income 10.2%
EPS (diluted) 13.1%
Free Cash Flow -3.7%
Current Ratio 6.6×
Quick Ratio 6.3×
Debt / Equity 0.0×
Net Debt / EBITDA -0.8×
Interest Coverage 77.8×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31